These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25464477)

  • 1. Ebola therapy: Developing new drugs or repurposing old ones?
    Lentini G; Habtemariam S
    Int J Cardiol; 2015 Jan; 179():325. PubMed ID: 25464477
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving attrition rates in Ebola virus drug discovery.
    Glisic S; Paessler S; Veljkovic N; Perovic VR; Prljic J; Veljkovic V
    Expert Opin Drug Discov; 2015; 10(9):1025-32. PubMed ID: 26125997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment.
    Schuler J; Hudson ML; Schwartz D; Samudrala R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29053626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious diseases. Debate erupts on 'repurposed' drugs for Ebola.
    Enserink M
    Science; 2014 Aug; 345(6198):718-9. PubMed ID: 25124404
    [No Abstract]   [Full Text] [Related]  

  • 5. Did Ebola survivors use plant medicines, and if so, which ones?
    Habtemariam S; Lentini G
    Phytother Res; 2015 Apr; 29(4):632. PubMed ID: 25640112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking the development of Ebola treatments.
    Gupta R
    Lancet Glob Health; 2014 Oct; 2(10):e563-4. PubMed ID: 25304627
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease?
    Almansa R; Eiros JM; Fedson D; Bermejo-Martin JF
    Lancet Glob Health; 2014 Dec; 2(12):e686. PubMed ID: 25433619
    [No Abstract]   [Full Text] [Related]  

  • 8. US signs contract with ZMapp maker to accelerate development of the Ebola drug.
    McCarthy M
    BMJ; 2014 Sep; 349():g5488. PubMed ID: 25189475
    [No Abstract]   [Full Text] [Related]  

  • 9. How to stop Ebola. The latest epidemic sheds light on a little-known industry that could change the way we treat virus diseases.
    Fry E
    Fortune; 2014 Sep; 170(4):10-2. PubMed ID: 25509578
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Repurposing for Ebola Virus Disease: Principles of Consideration and the Animal Rule.
    Bai JPF; Hsu CW
    J Pharm Sci; 2019 Feb; 108(2):798-806. PubMed ID: 30244014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola: public-private partnerships.
    Reperant LA; van de Burgwal LH; Claassen E; Osterhaus AD
    Science; 2014 Oct; 346(6208):433-4. PubMed ID: 25342793
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental Ebola drugs face tough test in war zone.
    Maxmen A
    Nature; 2018 Sep; 561(7721):14. PubMed ID: 30181631
    [No Abstract]   [Full Text] [Related]  

  • 14. Ebola: is there a hope from treatment with cardiovascular drugs?
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):524-6. PubMed ID: 25205490
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic science and the Ebola virus infection epidemic.
    DeVane CL
    Pharmacotherapy; 2014 Nov; 34(11):1115-7. PubMed ID: 25382095
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.
    Bai JPF
    J Pharm Sci; 2016 Oct; 105(10):3007-3012. PubMed ID: 27522921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History and the Ebola outbreak.
    Goozner M
    Mod Healthc; 2014 Aug; 44(33):24. PubMed ID: 25318255
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy and prophylaxis of Ebola virus infections.
    Feldmann H; Jones SM; Schnittler HJ; Geisbert T
    Curr Opin Investig Drugs; 2005 Aug; 6(8):823-30. PubMed ID: 16121689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
    Olszanecki R; Gawlik G
    Folia Med Cracov; 2014; 54(3):67-77. PubMed ID: 25694097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA allows second experimental drug to be tested in Ebola patients.
    McCarthy M
    BMJ; 2014 Aug; 349():g5103. PubMed ID: 25113141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.